Published in JAMA · View the paper (DOI)
A new study found that Ebola vaccines provide durable immune responses at one year after vaccination, with 100% of recipients retaining Ebola virus glycoprotein-specific antibodies. The heterologous primary and booster vaccination schedule showed long-lasting immunity, exceeding eight months after primary immunization.
Coverage from 2 institutions
- Ebola vaccines provide immune responses after 1 year JAMA Network · Mar 14, 2017 · first to report
- Experimental Ebola vaccine regimen induced durable immune response, study finds NIH/National Institute of Allergy and Infectious Diseases · Mar 14, 2017